ExodusPoint Capital Management LP Raises Position in CME Group Inc. (NASDAQ:CME)

ExodusPoint Capital Management LP boosted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 75.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 57,432 shares of the financial services provider’s stock after purchasing an additional 24,767 shares during the period. ExodusPoint Capital Management LP’s holdings in CME Group were worth $13,337,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Lake Street Advisors Group LLC raised its position in shares of CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock valued at $2,949,000 after purchasing an additional 6,453 shares during the period. Meyer Handelman Co. bought a new stake in CME Group during the 4th quarter valued at $6,144,000. Unified Investment Management purchased a new stake in shares of CME Group during the fourth quarter worth $503,000. Spire Wealth Management boosted its holdings in shares of CME Group by 37.4% in the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock worth $307,000 after acquiring an additional 359 shares during the period. Finally, AEGON ASSET MANAGEMENT UK Plc boosted its holdings in shares of CME Group by 19.3% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock worth $75,730,000 after acquiring an additional 52,862 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

NASDAQ:CME opened at $268.36 on Friday. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $271.22. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The business has a 50 day moving average of $252.20 and a 200 day moving average of $236.93. The company has a market capitalization of $96.71 billion, a price-to-earnings ratio of 27.75, a PEG ratio of 6.76 and a beta of 0.53.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group declared that its board has initiated a stock buyback plan on Thursday, December 5th that allows the company to buyback $3.00 billion in outstanding shares. This buyback authorization allows the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its shares are undervalued.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.86%. The ex-dividend date was Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s payout ratio is 51.71%.

Insider Activity at CME Group

In other CME Group news, insider Julie Winkler sold 11,592 shares of the stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the sale, the insider now owns 21,885 shares of the company’s stock, valued at $5,453,085.45. This represents a 34.63 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. The trade was a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock worth $6,871,496 in the last ninety days. 0.30% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CME. Erste Group Bank raised CME Group to a “strong-buy” rating in a report on Monday, March 17th. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective for the company in a research report on Monday, March 10th. Morgan Stanley upped their target price on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 19th. JPMorgan Chase & Co. raised their price target on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $269.00 price target on shares of CME Group in a report on Thursday. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $241.53.

Read Our Latest Stock Analysis on CME Group

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.